≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Maternal care for cervical incompetence

Endpoint Browser PheWeb

O15_MATERN_CARE_CERVICAL_INCOMPETENCE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — O34.3
  • Hospital discharge: ICD-9 — 6545|6546
  • Hospital discharge: ICD-8 — 63494
  • Cause of death: ICD-10 — O34.3
  • Cause of death: ICD-9 — 6545|6546
  • Cause of death: ICD-8 — 63494

2 out of 7 registries used, show all original rules.

1483

4. Check minimum number of events

None

1483

5. Include endpoints

None

1483

6. Filter based on genotype QC (FinnGen only)

1483

Control definitions (FinnGen only)

Control exclude
O15_MATERN_CARE_PELVIC_ABNORM

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF6v3

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 10979 10979 -
Only index persons 10647 10647 -
Unadjusted period prevalence (%)
Whole population 0.31 0.31 -
Only index persons 0.39 0.39 -
Median age at first event (years)
Whole population - 29.51 -
Only index persons - 29.48 -

-FinnGen-

Key figures

All Female Male
Number of individuals 1483 1483 -
Unadjusted period prevalence (%) 0.51 0.51 -
Median age at first event (years) 29.69 29.69 -

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1316
Matched controls
13160
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
63494
ICD-8 Finland
Other complications of pregnancy, Insufficientia cervicis
+∞
323.0
652
*
O34.3
ICD-10 Finland
Maternal care for cervical incompetence
9795.9
323.0
580
*
6545A
ICD-9 Finland
Abnormality of organs and soft tissues of pelvis, Cervical incompetence[INSUFFICIENTIA CERVICIS UTERI, RASKAUDEN AIKANA]
+∞
147.7
139
*
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
6.9
144.2
415
825
8702
FHL
Placement of Cerglagen during pregnancy
+∞
128.3
121
*
O60
ICD-10 Finland
Preterm labour and delivery
15.1
117.2
202
156
O34.2
ICD-10 Finland
Maternal care due to uterine scar from previous surgery
384.3
108.0
107
*
MAB00
NOMESCO Finland
Cerclage of cervix of pregnant uterus
+∞
101.4
96
*
63230
ICD-8 Finland
Haemorrhage of pregnancy, Threatened abortion
8.4
77.9
181
244
63497
ICD-8 Finland
Other complications of pregnancy, Partus prematurus imminens, alibi non classificabilis
8.6
73.3
168
221
64399
ICD-8 Finland
Spontaneous abortion, Without mention of sepsis or toxaemia
6.7
72.7
198
337
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
3.8
52.3
253
783
Z35.2
ICD-10 Finland
Supervision of pregnancy with other poor reproductive or obstetric history
10.3
51.3
104
109
O34.4
ICD-10 Finland
Maternal care for other abnormalities of cervix
+∞
48.2
46
*
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
3.5
46.2
242
792
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
2.7
43.9
359
1589
Y6099
ICD-8 Finland
Prenatal care and observation
4.0
39.1
169
467
MA2XE
NOMESCO Finland
Other obstetric ultrasound examination
3.5
34.9
177
558
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
3.5
34.3
172
537
Z87.5
ICD-10 Finland
Personal history of complications of pregnancy, childbirth and the puerperium
11.8
31.8
59
52
O30.0
ICD-10 Finland
Twin pregnancy
7.9
30.1
70
93
O20.0
ICD-10 Finland
Threatened abortion
5.4
28.6
88
171
MAB03
NOMESCO Finland
Removal of cerclage of cervix uteri before childbirth
+∞
28.2
27
*
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
2.2
25.9
307
1589
Z39.2
ICD-10 Finland
Routine postpartum follow-up
2.2
25.6
289
1463
6440B
ICD-9 Finland
Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS]
8.0
24.4
56
73
N88.3
ICD-10 Finland
Incompetence of cervix uteri
+∞
21.9
21
*
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
1.9
21.8
402
2465
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
2.3
21.5
215
1017
6440A
ICD-9 Finland
Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS IMMINENS]
5.8
21.5
62
112
Z35.9
ICD-10 Finland
Supervision of high-risk pregnancy, unspecified
4.1
21.0
84
215
65000
ICD-8 Finland
Delivery without mention of complication, Occipital presentation
1.8
20.8
539
3694
XMA22
NOMESCO Finland
General examination of pregnant woman
3.0
20.4
126
453
O20.9
ICD-10 Finland
Haemorrhage in early pregnancy, unspecified
3.8
20.0
86
235
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
2.5
19.8
168
730
63499
ICD-8 Finland
Other complications of pregnancy, Other
4.8
19.7
66
142
Z32.1
ICD-10 Finland
Pregnancy confirmed
2.2
19.5
209
1019
O41.1
ICD-10 Finland
Infection of amniotic sac and membranes
11.5
19.5
36
32
O30.00
ICD-10 Finland
Twin pregnancy with separate amniotic and chorionic sacs
14.9
19.4
32
22
W84
ICPC
Pregnancy high risk
3.4
18.7
93
287
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.7
18.5
533
3731
64300
ICD-8 Finland
Spontaneous abortion, With sepsis
9.7
18.4
37
39
O46.9
ICD-10 Finland
Antepartum haemorrhage, unspecified
5.3
17.7
54
105
SPAT1197
SPAT
Extensive health check-up of expecting family
2.0
17.5
271
1537
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.1
17.4
233
1247
SPAT1379
SPAT
Health check-up of pregnant person
2.0
17.2
250
1387
ZXD05
NOMESCO Finland
Urgent procedure
1.8
17.1
397
2590
O34.0
ICD-10 Finland
Maternal care for congenital malformation of uterus
+∞
16.7
16
*
W78
ICPC
Pregnancy
1.9
16.1
297
1788
O84.2
ICD-10 Finland
Multiple delivery, all by caesarean section
17.4
15.6
24
14
O32.1
ICD-10 Finland
Maternal care for breech presentation
3.3
15.6
80
253
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
2.6
15.6
117
471
8502
FHL
Evacuation and abrasion
2.9
15.3
95
344
N97.0
ICD-10 Finland
Female infertility associated with anovulation
4.0
15.1
61
159
FM1QE
NOMESCO Finland
Extensive ultrasound of fetal heart
8.0
14.9
33
42
Z37.2
ICD-10 Finland
Twins, both liveborn
16.7
14.8
23
14
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
6.3
14.2
37
60
6340A
ICD-9 Finland
Spontaneous abortion, Complicated by genital tract and pelvic infection
4.0
14.0
56
145
O35.8
ICD-10 Finland
Maternal care for other (suspected) fetal abnormality and damage
4.1
13.0
50
125
SPAT1380
SPAT
Postpartum check-up
1.9
13.0
207
1175
Z35.0
ICD-10 Finland
Supervision of pregnancy with history of infertility
3.3
13.0
65
203
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
2.0
12.9
169
892
ZXE00
NOMESCO Finland
One hour or less
1.6
12.7
522
3903
64394
ICD-8 Finland
NA
70.6
12.6
14
*
MBA03
NOMESCO Finland
Curettage of uterus after delivery or abortion
3.3
12.6
63
197
O42.9
ICD-10 Finland
Premature rupture of membranes, unspecified
2.9
12.5
77
278
O03.9
ICD-10 Finland
Spontaneous abortion, Complete or unspecified, without complication
2.6
12.2
87
343
6400A
ICD-9 Finland
Haemorrhage in early pregnancy, Threatened abortion
6.2
12.1
32
53
63495
ICD-8 Finland
Other complications of pregnancy, Effluxus liquoris amnii praetemporarius
7.9
12.1
27
35
O82.10
ICD-10 Finland
Delivery by emergency caesarean section
2.9
12.1
74
265
O82.0
ICD-10 Finland
Delivery by elective caesarean section
3.6
12.0
54
156
MAA00
NOMESCO Finland
Amniocentesis
4.2
11.9
44
107
66100
ICD-8 Finland
Occipital presentation
5.0
11.5
36
74
O02.1
ICD-10 Finland
Missed abortion
2.4
11.5
95
406
63496
ICD-8 Finland
Other complications of pregnancy, Labores inhibiti
4.6
11.3
38
84
Z35.1
ICD-10 Finland
Supervision of pregnancy with history of abortive outcome
7.7
11.2
25
33
O03.1
ICD-10 Finland
Spontaneous abortion, Incomplete, complicated by delayed or excessive haemorrhage
4.3
11.1
40
95
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
2.3
10.9
102
464
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.8
10.8
186
1083
B01AB05
ATC
enoxaparin; parenteral
1.6
10.5
362
2568
O34.1
ICD-10 Finland
Maternal care for tumour of corpus uteri
110.9
10.4
11
*
O47.9
ICD-10 Finland
False labour, unspecified
3.8
10.3
42
112
63490
ICD-8 Finland
Other complications of pregnancy, Abortus habitualis
23.6
10.2
14
6
C08CA05
ATC
nifedipine; systemic
2.5
10.2
79
328
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.7
9.8
213
1334
O03.4
ICD-10 Finland
Spontaneous abortion, Incomplete, without complication
3.1
9.6
51
169
64598
ICD-8 Finland
Other abortion
4.4
9.6
33
76
G02CA02
ATC
buphenine; parenteral
30.2
9.4
12
*
ZXD00
NOMESCO Finland
Emergency procedure
3.1
9.4
49
160
O72.2
ICD-10 Finland
Delayed and secondary postpartum haemorrhage
3.6
9.4
41
117
O30.01
ICD-10 Finland
Twin pregnancy with a shared chorionic sac and a separate amniotic sac
21.9
9.4
13
6
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.4
9.3
76
324
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
9.1
484
3752
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
9.0
345
2496
O03.5
ICD-10 Finland
Spontaneous abortion, Complete or unspecified, complicated by genital tract and pelvic infection
18.7
8.9
13
7
O64.1
ICD-10 Finland
Obstructed labour due to breech presentation
5.3
8.9
26
50
W29
ICPC
Pregnancy symptom/complaint other
2.7
8.6
56
213
WX306
NOMESCO Finland
Lumbar epidural anesthesy
2.0
8.2
104
544
WX320
NOMESCO Finland
Spinalanesthesy
1.6
8.2
262
1814
MBA40
NOMESCO Finland
Pharmacological evacuation of uterus after abortion
3.5
8.1
36
105
MBA96
NOMESCO Finland
Other removal of retained products of conception after delivery or abortion
3.3
8.1
38
116
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.8
8.1
139
811
G02CB01
ATC
bromocriptine; systemic
3.1
8.0
41
133
O35.9
ICD-10 Finland
Maternal care for (suspected) fetal abnormality and damage, unspecified
5.1
8.0
24
48
Z35
ICD-10 Finland
Supervision of high-risk pregnancy
4.4
8.0
27
62
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
2.0
8.0
104
548
O84.0
ICD-10 Finland
Multiple delivery, all spontaneous
5.4
7.8
22
41
N96
ICD-10 Finland
Habitual aborter
5.4
7.8
22
41
63299
ICD-8 Finland
Haemorrhage of pregnancy, Other and unspecified
5.3
7.7
22
42
Q51.2
ICD-10 Finland
Other doubling of uterus
25.2
7.6
10
*
O84.8
ICD-10 Finland
Other multiple delivery
10.1
7.5
14
14
SPAT1357
SPAT
Monitoring of problem during pregnancy
2.5
7.5
55
222
W92
ICPC
Compl labour/ delivery livebirth
2.8
7.4
44
158
65696
ICD-8 Finland
Delivery complicated by malpresentation of foetus, Complete or incomplete breech presentation
5.1
7.4
22
44
N97.9
ICD-10 Finland
Female infertility, unspecified
2.0
7.4
90
462
LDD00
NOMESCO Finland
Suture of cervix uteri
80.5
7.4
8
*
6225A
ICD-9 Finland
Noninflammatory disorders of cervix, Incompetence of cervix
80.5
7.4
8
*
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
1.6
7.3
219
1489
O80.0
ICD-10 Finland
Spontaneous vertex delivery
1.4
7.2
380
2913
O36.5
ICD-10 Finland
Maternal care for poor fetal growth
2.5
7.2
53
214
64595
ICD-8 Finland
Other abortion, Haemorrhagia post abortum NUD
7.3
7.2
16
22
W85
ICPC
Gestational diabetes
2.1
7.1
74
356
O42.1
ICD-10 Finland
Premature rupture of membranes, onset of labour after 24 hours
3.9
7.1
27
70
MAC01
NOMESCO Finland
Rupture of aminiotic membrane for induction of labor
3.0
7.1
38
129
MBA30
NOMESCO Finland
Manual removal of placenta from delivered uterus
3.1
7.0
36
118
SPAT1196
SPAT
Monitoring of normal pregnancy
1.8
7.0
122
713
MA3AE
NOMESCO Finland
Combined first trimester screening
2.0
6.9
88
460
G03GA01
ATC
chorionic gonadotrophin; parenteral
2.2
6.9
66
309
MBA05
NOMESCO Finland
Curettage of uterus after abortion
4.4
6.9
23
53
O21.9
ICD-10 Finland
Vomiting of pregnancy, unspecified
3.3
6.8
32
99
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
2.9
6.7
37
128
MBC30
NOMESCO Finland
Repair of partial rupture of perineum
3.1
6.7
34
111
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
6.7
528
4334
O72.0
ICD-10 Finland
Third-stage haemorrhage
2.7
6.6
43
163
A02BC01
ATC
omeprazole; systemic
1.4
6.6
314
2355
O73.0
ICD-10 Finland
Retained placenta without haemorrhage
4.2
6.5
23
56
O03.0
ICD-10 Finland
Spontaneous abortion, Incomplete, complicated by genital tract and pelvic infection
5.1
6.5
19
38
K02.1
ICD-10 Finland
Caries of dentine
1.3
6.4
715
6181
8831
FHL
Uterine exploration and / or scraping or suction emptying (ad 24 hours)
6.6
6.3
15
23
O36.4
ICD-10 Finland
Maternal care for intrauterine death
6.0
6.3
16
27
N20.1
ICD-10 Finland
Calculus of ureter
3.0
6.3
33
111
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
11.1
6.3
11
10
63298
ICD-8 Finland
Haemorrhage of pregnancy, Alia definita
11.1
6.3
11
10
8703
FHL
Removal of Cerglagen under anesthesia
+∞
6.3
6
*
O02.0
ICD-10 Finland
Blighted ovum and nonhydatidiform mole
2.4
6.2
51
221
64594
ICD-8 Finland
Other abortion, Retentio ovi (partialis)
2.9
6.2
36
127
62191
ICD-8 Finland
Other diseases of cervix, Dysplasia portionis uteri
4.5
6.2
20
45
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
1.6
6.2
164
1084
B02AA02
ATC
tranexamic acid; systemic
1.5
6.1
226
1611
O03.3
ICD-10 Finland
Spontaneous abortion, Incomplete, with other and unspecified complications
8.6
6.1
12
14

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40761536) Microorganisms panel - Urine sediment
240
1185
2.22
25.55
4.7
3.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
165
733
2.41
22.36
1.8
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
140
644
2.30
17.43
1.9
1.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
123
550
2.35
16.34
1.6
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
253
1484
1.85
16.17
1.7
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
509
3622
1.62
16.08
4.1
3.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
486
3541
1.55
13.34
4.6
4.0
estimate
0.0
0.0
1.08
240
1273
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
197
1169
1.79
11.94
3.7
3.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
802
6639
1.45
11.09
5.3
4.9
estimate
0.0
0.0
0.50
236
1280
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
172
1002
1.81
11.06
3.1
2.2
u/l
6344.1
6293.1
0.01
102
434
(3013826) Glucose [Moles/volume] in Serum or Plasma
831
6930
1.45
11.02
4.2
4.1
mmol/l
6.5
6.4
0.42
767
6309
(3029396) Erythrocyte agglutination [Presence] in Blood
26
58
4.54
10.97
3.3
3.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
635
5043
1.45
10.87
4.2
3.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
806
6701
1.44
10.75
4.2
3.7
estimate
0.0
0.0
1.08
231
1261
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
168
987
1.79
10.49
3.6
3.1
mmol/l
1.2
1.2
0.04
147
837
(3035350) Ketones [Presence] in Urine by Test strip
792
6588
1.43
10.38
4.1
3.7
estimate
0.0
0.0
0.50
226
1244
(3019832) Treponema pallidum Ab [Presence] in Serum
333
2342
1.54
10.30
1.9
1.6
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
12
13
9.30
9.88
1.2
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
399
2951
1.48
9.62
2.0
1.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1023
8989
1.45
9.48
5.5
4.5
e6/l
3225.5
1849.9
0.23
28
104
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
267
1827
1.56
9.25
2.2
1.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
160
965
1.74
9.11
1.5
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
153
923
1.73
8.70
2.5
2.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1035
9210
1.41
8.21
5.2
4.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
507
4017
1.40
8.16
3.4
3.2
ng/l
29.6
36.0
0.18
280
2380
(1761868) Lipid panel - Serum or Plasma
546
4434
1.37
7.39
3.0
2.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
538
4361
1.37
7.36
3.0
2.8
—
—
—
0
0
(3012501) Base excess in Blood by calculation
50
223
2.29
6.79
3.9
3.1
mmol/l
2.1
2.6
0.91
33
160
(3000850) Epithelial cells [#/volume] in Urine
323
2443
1.41
6.60
2.5
2.5
e6/l
8.4
8.5
0.06
285
2128
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
44
188
2.38
6.59
1.5
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
330
2513
1.40
6.47
1.7
1.6
pmol/l
23166494.8
26586399.1
0.05
259
2065
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
739
6367
1.32
6.42
5.7
3.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
671
5735
1.31
6.05
10.5
8.6
e9/l
0.0
0.0
0.01
567
4689
(3002582) Erythrocytes [#/volume] in Urine
435
3500
1.34
5.99
3.0
3.0
e6/l
307.5
54.1
0.71
346
2610
(3002385) Erythrocyte distribution width [Ratio]
1188
11019
1.39
5.98
16.9
14.8
%
13.5
13.6
0.09
1168
10775
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
69
371
1.90
5.78
1.4
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
33
133
2.51
5.64
1.2
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1350
12857
1.56
5.60
13.6
12.0
mg/l
18.8
20.1
0.79
1115
9950
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
461
3781
1.32
5.47
2.9
2.4
u/l
56.1
56.2
0.02
406
3452
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
721
6285
1.29
5.37
5.9
5.6
umol/l
9.5
10.0
1.24
658
5917
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
216
1580
1.43
5.26
2.2
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
504
4218
1.30
5.08
2.3
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
50
253
2.01
5.02
4.2
3.6
%
55.6
57.5
0.40
50
253
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
24
90
2.69
4.76
1.5
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
22
80
2.78
4.62
1.5
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
36
166
2.20
4.61
2.9
2.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1348
12912
1.48
4.57
14.1
13.1
mmol/l
3.9
3.9
0.25
1316
12496
(3032080) INR in Blood by Coagulation assay
499
4216
1.28
4.57
7.1
6.9
inr
1.1
1.1
0.93
211
1283
(3019550) Sodium [Moles/volume] in Serum or Plasma
1345
12882
1.47
4.52
13.9
13.0
mmol/l
139.6
139.6
0.23
1318
12493
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
14
39
3.61
4.49
1.5
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
47
245
1.95
4.38
3.8
3.4
e9/l
3.8
4.1
0.38
47
245
(3018095) Leukocytes [#/volume] in Urine
511
4366
1.26
4.19
3.6
3.5
e6/l
106.4
85.3
0.38
368
2850
(3026782) Osmolality of Urine
283
2242
1.32
4.18
2.4
2.6
mosm/kgh2o
503.1
509.0
0.18
240
1895
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
41
208
2.00
4.14
1.9
1.6
mmol/l
7.6
7.6
0.03
22
122
(40761511) CBC panel - Blood by Automated count
1393
13470
1.56
4.11
14.1
11.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
228
1756
1.35
4.07
2.1
2.3
umol/l
13.0
13.5
0.47
205
1619
(21494815) CD4 cells/100 lymphocytes in Specimen
21
81
2.62
3.98
1.3
1.8
%
46.2
50.9
—
5
7
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
100
1467
0.66
3.98
6.8
5.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
644
5673
1.24
3.96
2.0
2.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
183
1368
1.39
3.93
1.5
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1170
11020
1.29
3.91
5.0
4.5
pmol/l
14.5
14.6
0.91
1066
10147
(3009214) Lutropin [Units/volume] in Serum or Plasma
64
384
1.70
3.83
1.3
1.2
u/l
10.4
12.1
0.70
58
314
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
450
3823
1.25
3.81
1.7
1.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
55
317
1.76
3.79
2.4
2.1
umol/l
5.0
4.5
0.23
40
229
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
42
224
1.90
3.71
1.4
1.3
u/ml
89.8
111.7
0.87
13
48
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
992
9188
1.24
3.69
3.5
3.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
134
962
1.43
3.64
4.1
4.0
%
0.0
1.0
0.85
25
182
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
45
248
1.84
3.60
1.5
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
31
151
2.08
3.53
1.5
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
41
221
1.88
3.52
2.6
2.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
380
3194
1.26
3.49
2.9
2.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
487
4210
1.23
3.46
5.6
5.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
229
1807
1.32
3.46
3.3
3.0
mmol/l
0.8
0.8
0.10
214
1682
(3023511) Choriogonadotropin [Units/volume] in Urine
84
555
1.54
3.44
1.4
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
12
37
3.26
3.34
1.4
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
26
121
2.17
3.33
2.3
1.9
pg
32.5
31.6
0.54
26
121
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1022
9542
1.23
3.31
7.4
7.0
u/l
74.2
75.2
0.39
955
8937
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1258
12031
1.30
3.27
12.5
11.0
ml/min/173m2
85.8
85.1
0.51
1043
9688
(3002179) Metamyelocytes/100 leukocytes in Blood
133
975
1.40
3.23
3.8
3.7
%
0.6
0.6
0.02
22
171
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
354
2986
1.24
3.12
1.8
1.8
mg/l
1.3
1.0
1.00
269
2249
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
118
855
1.41
3.08
1.7
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
112
804
1.43
3.08
1.2
1.3
iu/l
22.0
24.3
0.33
101
678
(40760892) CBC W Ordered Manual Differential panel - Blood
356
3010
1.24
3.06
4.5
4.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
185
1442
1.32
3.05
1.3
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
136
1015
1.37
2.99
4.1
3.9
%
0.2
0.1
0.41
26
221
(3017181) Myelocytes/100 leukocytes in Blood
141
1059
1.37
2.98
4.0
3.8
%
1.1
0.9
0.20
26
242
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
186
1457
1.32
2.97
2.1
2.4
%
21.5
22.6
0.50
150
1236
(3030467) Casts [#/volume] in Urine by Automated count
378
3228
1.23
2.95
3.0
2.9
e6/l
0.3
0.4
0.96
294
2360
(3022806) Fractional oxyhemoglobin in Capillary blood
27
135
2.02
2.91
1.5
1.9
%
90.9
90.2
0.31
27
135
(3044889) 12 lead EKG panel
902
8369
1.20
2.90
3.9
3.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
32
171
1.89
2.87
1.3
1.3
nmol/l
1.3
1.6
0.56
27
143
(3048689) Calprotectin [Mass/mass] in Stool
225
1817
1.28
2.86
2.2
2.2
ug/g
105.8
107.4
0.03
168
1382
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1296
12488
1.30
2.85
5.7
5.3
mu/l
1.8
1.9
1.20
1202
11566
(3018418) pH of Serum or Plasma
420
3639
1.22
2.83
4.1
3.5
ph
7.4
7.4
0.56
129
668
(3004789) Transferrin [Mass/volume] in Serum or Plasma
200
1594
1.29
2.82
2.0
2.3
g/l
2.5
2.4
0.70
177
1475
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
12
42
2.87
2.75
1.6
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
40
234
1.73
2.70
1.3
1.2
u/ml
3.4
4.5
—
10
75
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
6
10
6.02
2.70
1.0
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
397
3438
1.21
2.68
2.3
2.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
38
220
1.75
2.66
1.1
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
491
4341
1.20
2.65
3.1
3.3
mmol/l
2.4
2.4
1.00
434
3799
(40768797) Stomach Pathology biopsy report
227
1856
1.26
2.61
1.2
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
122
917
1.36
2.59
2.7
2.8
g/l
10.6
10.1
0.43
112
834
(40767503) Oxygen content in Capillary blood by calculation
36
208
1.75
2.55
2.4
2.4
%
15.8
16.4
0.29
12
99
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
20
94
2.14
2.55
1.2
1.1
ratio
1.1
1.0
—
9
39
(3018677) aPTT in Platelet poor plasma by Coagulation assay
199
1607
1.28
2.54
2.9
2.0
s
29.4
29.2
0.12
192
1552
(3043238) Trisomy 21 risk [Likelihood] in Fetus
92
662
1.42
2.54
1.8
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
364
3141
1.21
2.53
1.8
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
282
2376
1.23
2.48
2.5
2.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
19
89
2.15
2.45
1.1
1.2
—
—
—
0
0
(3036489) Thrombin time
71
490
1.47
2.45
2.4
2.1
s
20.6
20.8
0.13
53
427
(3003338) MCHC [Mass/volume]
1056
11075
0.84
2.41
17.2
15.7
g/l
332.1
331.2
2.98
1050
10995
(3011412) CD3 cells [#/volume] in Blood
21
104
2.03
2.36
1.7
2.1
e9/l
1.3
1.3
0.07
13
70
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
119
1542
0.75
2.34
4.3
4.2
%
33.8
33.4
0.18
81
1031
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
105
785
1.36
2.33
1.6
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
95
699
1.38
2.32
1.4
1.6
mu/l
261.3
303.0
1.34
82
615
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
105
786
1.36
2.31
1.6
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
705
6484
1.17
2.29
3.1
2.8
ug/l
75.9
78.9
0.23
656
6040
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
155
1230
1.29
2.28
1.9
1.8
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
41
255
1.63
2.26
3.5
3.6
mg/l
32.2
20.1
0.90
27
154
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
104
782
1.35
2.24
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
104
783
1.35
2.22
1.6
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
10
36
2.79
2.20
1.4
1.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1015
9621
1.17
2.19
4.2
4.1
mm/h
11.1
11.6
0.65
947
8904
(3042936) Bacteria identified in Isolate by Culture
199
1639
1.25
2.17
1.8
1.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
592
5388
1.16
2.17
5.0
5.0
mmol/l
1.2
1.2
0.42
535
4857
(4034850)
23
411
0.55
2.16
6.4
8.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
166
1339
1.27
2.16
4.1
4.7
mmol/l
1.0
1.0
0.16
161
1234
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1266
12247
1.23
2.13
4.4
4.2
mmol/l
5.7
5.7
0.23
1135
11202
(3045414) Leukocytes [Presence] in Urine
88
650
1.38
2.13
1.9
1.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
461
4120
1.17
2.12
3.3
2.9
u/l
28.5
30.7
0.43
436
3918
(3013512) EKG study
378
3326
1.18
2.10
3.5
3.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
252
2137
1.22
2.09
2.3
2.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
649
5961
1.16
2.08
5.7
5.7
mmol/l
1.2
1.2
0.70
505
5019
(1616796) Gas panel - Central venous blood
34
207
1.66
2.05
4.5
3.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
94
709
1.35
2.01
2.0
1.8
g/l
1.5
1.4
0.16
87
639
(3022096) Basophils/100 leukocytes in Blood
634
5827
1.15
1.99
5.3
5.7
%
0.7
0.7
0.01
591
5404
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
13
57
2.29
1.98
1.1
1.1
%
102.9
92.4
—
7
29
(3025941) Bacteria identified in Stool by Culture
105
808
1.32
1.96
1.3
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
325
2838
1.19
1.96
2.2
2.3
umol/l
3893.3
3725.2
0.03
270
2447
(3047352) Trisomy 18 risk [Likelihood] in Fetus
86
643
1.36
1.95
1.7
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
307
2672
1.19
1.92
4.5
3.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
144
1161
1.27
1.90
4.3
4.5
u/l
246.9
247.4
0.01
138
1102
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
382
3390
1.17
1.90
1.7
1.6
mmol/l
1.3
1.3
0.05
299
2886
(3005033) Fetal Nuchal fold Thickness US
85
638
1.35
1.89
1.7
1.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
655
6051
1.15
1.89
5.5
5.9
%
8.0
8.1
0.51
612
5642
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
380
3375
1.17
1.87
1.3
1.3
u/ml
0.7
1.5
2.59
99
877
(3042631) Mycobacterium sp identified in Specimen
23
129
1.80
1.86
2.7
2.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
35
221
1.60
1.86
1.9
2.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
651
6020
1.15
1.83
5.3
5.7
%
2.8
2.7
0.92
605
5571
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
66
479
1.40
1.81
2.2
2.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
35
2.58
1.80
3.0
4.9
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
9
35
2.58
1.80
1.6
1.1
pmol/l
17.4
15.6
—
9
30
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
30
184
1.64
1.79
1.1
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
457
4131
1.15
1.77
3.2
2.1
—
—
—
0
0
(4306422)
34
217
1.58
1.74
1.3
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
12
54
2.23
1.74
1.4
1.6
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
12
54
2.23
1.74
1.1
1.1
%
111.7
96.9
—
7
27
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
9
36
2.51
1.74
2.7
1.8
—
112.4
—
0
8
(3002030) Lymphocytes/100 leukocytes in Blood
672
6255
1.14
1.67
5.3
5.7
%
29.1
29.2
0.12
622
5813
(3019309) Folate [Moles/volume] in Red Blood Cells
231
1987
1.19
1.66
1.9
1.7
nmol/l
1288.1
1176.8
0.92
175
1468
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
18
97
1.87
1.66
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
49
343
1.44
1.65
2.3
1.9
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
5
14
3.58
1.61
1.4
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
72
944
0.75
1.60
3.3
3.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
11
50
2.21
1.57
1.2
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
101
801
1.28
1.56
1.6
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
16
85
1.89
1.55
1.4
2.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
51
701
0.72
1.55
1.5
1.5
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
20
115
1.75
1.53
1.3
1.3
umol/l
6.8
5.4
0.54
20
110
(3024731) MCV [Entitic volume]
1451
14354
1.50
1.50
20.8
18.1
fl
90.7
90.6
0.12
1441
14169
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
72
1.95
1.49
1.6
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
44
309
1.44
1.49
1.9
1.7
—
—
—
0
0
(3035941) MCH [Entitic mass]
1451
14356
1.50
1.47
20.8
18.1
pg
30.1
30.1
0.53
1441
14169
(3026361) Erythrocytes [#/volume] in Blood
1451
14356
1.50
1.47
20.8
18.2
e12/l
4.4
4.4
0.36
1425
13970
(3016228) CD19 cells/100 cells in Blood
10
45
2.23
1.46
1.4
1.9
%
8.3
7.4
—
10
45
(21494814) CD8 cells/100 lymphocytes in Specimen
10
45
2.23
1.46
1.4
1.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
548
5069
1.13
1.46
4.8
4.2
g/l
35.8
36.0
0.40
505
4703
(3007461) Platelets [#/volume] in Blood
1450
14345
1.49
1.46
20.9
18.2
e9/l
263.0
264.9
0.58
1428
13991
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
58
430
1.36
1.45
1.8
2.0
g/l
1.2
1.5
1.46
48
383
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
101
810
1.26
1.44
1.6
1.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1451
14358
1.49
1.44
20.9
18.2
e9/l
7.0
6.7
3.57
1425
13966
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
29
188
1.55
1.43
1.1
1.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
660
6180
1.12
1.43
5.1
5.5
%
56.9
56.5
0.32
616
5760
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
123
1011
1.24
1.42
2.6
3.1
pmol/l
4.4
4.5
0.35
114
894
(3036481) Cortisol [Moles/volume] in Serum or Plasma
152
1278
1.21
1.42
2.3
2.0
nmol/l
387.7
377.6
0.20
143
1160
(1175426) CD3 cells/100 lymphocytes in Blood
16
88
1.83
1.41
1.4
1.9
%
74.9
75.8
0.12
16
83
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
16
88
1.83
1.41
1.4
1.9
%
12.2
11.8
—
6
40
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
50
364
1.39
1.40
1.8
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
317
2838
1.15
1.39
3.6
4.1
kg/l
1.0
1.0
0.35
71
446
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
29
2.42
1.39
1.0
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
29
2.42
1.39
1.0
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1451
14363
1.47
1.38
21.0
18.3
g/l
132.0
132.1
0.09
1441
14177
(3051611) Lipemic interference index of Serum or Plasma
5
120
0.41
1.37
4.2
2.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
21
127
1.66
1.37
1.4
1.2
u/l
59.3
55.5
0.17
16
91
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
188
1619
1.18
1.36
1.5
1.4
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
0
37
0.00
1.34
0.0
1.3
—
0.4
—
0
23
(3019225) pH of Specimen
101
1232
0.81
1.30
3.7
3.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
33
226
1.47
1.29
1.3
1.3
u/ml
3.4
4.8
0.54
11
98
(3044290) Cell count panel - Cerebral spinal fluid
38
268
1.43
1.28
1.7
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
18
2.78
1.28
4.8
3.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
205
1788
1.17
1.28
2.7
2.7
e6/l
4.4
4.2
0.08
111
897
(3002032) Base excess in Venous blood by calculation
66
844
0.77
1.27
2.9
3.1
mmol/l
1.6
1.9
0.47
59
693
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
157
1340
1.19
1.27
2.1
2.2
umol/l
6.7
6.3
0.10
125
1140
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
9
44
2.05
1.27
1.0
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
25
2.41
1.24
1.3
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
25
2.41
1.24
1.3
1.2
%
101.2
104.5
—
6
25
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
10
49
2.05
1.22
1.0
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
53
400
1.34
1.22
2.7
2.2
%
95.8
94.9
0.10
44
374
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
5
19
2.64
1.21
1.0
1.0
u/ml
5.0
1.3
—
5
12
(44806071)
5
19
2.64
1.21
1.6
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
41
297
1.39
1.21
1.2
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
30
205
1.47
1.20
1.1
1.3
nmol/l
0.6
0.6
0.46
30
197
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
13
71
1.84
1.19
1.2
1.7
u/field
1.0
2.6
—
7
53
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
307
2773
1.14
1.19
3.0
2.8
ng/l
702.8
818.7
0.56
255
2300
(3020874) Milk IgE Ab [Units/volume] in Serum
16
94
1.71
1.17
1.0
1.1
u/ml
0.2
3.7
—
5
26
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
79
1.78
1.17
1.5
1.5
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
34
0.00
1.16
0.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
361
3300
1.12
1.15
4.8
4.0
mg/mmol
12.0
8.4
0.59
197
1924
(3024932) HLA-DR beta [Type]
5
20
2.50
1.15
1.2
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
35
0.00
1.15
0.0
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
288
2600
1.13
1.13
1.3
1.3
iu/ml
25.0
31.0
0.35
80
823
(3035637) Corticotropin [Mass/volume] in Plasma
22
143
1.55
1.11
1.9
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
112
940
1.21
1.10
1.3
1.3
u/ml
252.4
170.8
0.30
98
864
(3009508) Creatinine [Moles/volume] in Urine
384
3532
1.12
1.10
3.5
3.2
mmol/l
7.0
6.7
0.49
324
2997
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1377
13569
1.21
1.09
10.5
9.7
u/l
23.8
23.3
0.56
1323
13067
(3045424) Erythrocytes [Presence] in Urine
33
235
1.41
1.09
1.4
1.7
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
23
152
1.52
1.09
4.3
4.0
u/ml
91.4
117.5
—
9
43
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
53
408
1.31
1.09
1.1
1.1
u/ml
0.7
4.9
—
6
56
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
18
112
1.61
1.09
1.1
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
56
714
0.78
1.08
5.1
2.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
419
0.71
1.07
7.1
2.4
g/l
3.6
3.8
0.30
24
314
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
419
0.71
1.07
7.1
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
419
0.71
1.07
7.1
2.4
g/l
7.7
7.5
0.24
25
327
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
16
97
1.66
1.07
1.1
1.2
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
7
33
2.13
1.05
1.7
1.1
nmol/l
6.9
5.6
—
7
33
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
31
429
0.72
1.05
1.2
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
15
90
1.67
1.04
1.1
1.2
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
5
22
2.28
1.03
1.0
1.0
u/ml
2.5
0.0
—
5
15
(3024471) HLA-A [Type]
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
215
0.60
1.03
5.6
4.4
—
270.7
—
0
24
(21494434) Karyotype in Bone marrow
14
83
1.69
1.01
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
32
437
0.73
1.01
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
16
99
1.62
1.00
1.1
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
35
2.00
1.00
1.1
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
129
1110
1.18
0.99
2.6
2.7
%
1.7
1.8
1.30
117
989
(3002619) Bacteria identified in Specimen by Culture
0
29
0.00
0.97
0.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
19
124
1.54
0.97
2.2
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
18
116
1.56
0.96
1.4
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
48
372
1.30
0.96
1.4
1.4
ug/g
244.1
310.2
1.27
23
204
(3004119) Hemoglobin [Mass/volume] in Venous blood
43
557
0.77
0.96
2.0
2.6
g/l
135.2
128.2
1.55
43
543
(40758558) Short blood count panel - Blood
307
3342
0.90
0.95
5.8
6.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
20
133
1.51
0.94
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
32
431
0.74
0.94
1.2
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
30
217
1.39
0.94
1.0
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
28
200
1.41
0.94
1.4
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
35
260
1.35
0.93
1.9
2.2
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
6
27
2.23
0.93
1.0
1.0
u/ml
10.5
0.3
—
6
20
(3008898) HLA-B27 [Presence]
70
572
1.23
0.93
1.1
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
10
171
0.58
0.92
1.2
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
26
360
0.72
0.91
2.1
2.8
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
38
288
1.33
0.90
1.4
1.3
e6/l
4.2
21.4
1.34
30
220
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
29
2.07
0.89
1.7
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
29
2.07
0.89
1.7
2.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
190
1699
1.14
0.88
1.8
1.8
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
42
1.91
0.88
1.3
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
195
1747
1.13
0.88
1.6
1.5
—
—
—
0
0
(4010399)
73
876
0.82
0.86
1.5
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
14
88
1.60
0.84
5.6
5.9
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
30
222
1.36
0.84
1.2
1.1
iu/ml
30.4
2567.0
—
9
51
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
399
0.75
0.83
7.1
2.4
g/l
3.1
3.1
0.09
23
321
(40768795) Lymph node Pathology biopsy report
17
113
1.51
0.82
1.1
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
307
2838
1.10
0.81
1.5
1.5
g/l
2.1
2.2
0.36
182
1684
(3016018) Differential panel - Cerebral spinal fluid
19
130
1.47
0.81
1.5
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
28
207
1.36
0.79
1.2
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
0
24
0.00
0.79
0.0
1.4
—
28.2
—
0
19
(3021960) Folate [Moles/volume] in Serum or Plasma
296
2736
1.10
0.78
1.6
1.5
nmol/l
21.8
21.9
0.02
245
2323
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
5
96
0.52
0.78
9.6
12.1
mmol/l
0.5
0.6
—
5
90
(3000330) Specific gravity of Urine by Test strip
75
631
1.20
0.78
3.0
2.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
338
3149
1.10
0.76
3.8
3.3
mg/l
258.9
368.9
0.21
195
1821
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
37
288
1.29
0.76
1.6
1.4
e6/l
849.0
388.2
0.26
31
233
(4198724)
9
53
1.70
0.75
1.4
1.8
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
14
91
1.54
0.75
1.7
1.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
339
3163
1.09
0.74
2.2
2.1
mg/l
2.8
2.9
0.07
288
2688
(4035726)
128
1131
1.14
0.74
1.5
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
107
0.56
0.72
1.7
1.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
10
159
0.63
0.72
1.4
1.5
—
21.0
—
0
8
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
46
373
1.24
0.69
1.3
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
27
1.85
0.68
2.8
2.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1265
12459
1.10
0.68
4.3
4.1
mmol/l
4.8
4.8
0.13
1164
11577
(3037522) Nuclear Ab [Titer] in Serum
212
1943
1.11
0.68
1.3
1.4
titre
700.6
607.9
0.16
31
428
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
180
0.66
0.68
1.9
2.2
—
196.4
—
0
7
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
75
873
0.85
0.67
1.0
1.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
129
1150
1.13
0.67
1.7
1.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
367
3454
1.08
0.66
2.1
2.1
u/l
183.7
168.2
0.13
337
3250
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
269
2498
1.09
0.66
1.2
1.3
u/ml
6.8
12.9
0.99
98
986
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
30
382
0.78
0.64
2.9
3.5
%
41.3
48.0
0.88
30
376
(3009445) Proteinase 3 Ab [Units/volume] in Serum
38
470
0.80
0.64
1.1
1.6
—
8.9
—
0
9
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
51
611
0.83
0.64
1.3
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
15
104
1.45
0.62
1.1
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
319
2994
1.08
0.62
3.7
3.4
%
98.3
96.1
0.96
308
2899
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
49
1.64
0.62
1.0
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
863
8392
1.07
0.61
3.1
2.8
u/l
35.1
37.8
0.88
811
7816
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
38
307
1.24
0.61
1.4
1.7
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
8
50
1.60
0.61
1.0
1.0
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
33
411
0.80
0.60
1.8
2.3
%
0.7
0.7
0.44
33
393
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
31
245
1.27
0.60
1.6
1.6
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
22
0.00
0.59
0.0
2.2
—
3.7
—
0
11
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
21
157
1.34
0.59
1.2
1.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
10
64
1.57
0.58
1.0
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
184
1691
1.10
0.58
1.3
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
116
0.60
0.57
1.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
21
158
1.33
0.57
1.2
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
54
1.48
0.57
1.8
1.3
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
8
54
1.48
0.57
1.5
1.3
pmol/l
16.4
14.0
—
8
42
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
54
1.48
0.57
1.8
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
26
203
1.29
0.56
1.5
1.2
—
—
—
0
0
(4268621)
21
159
1.33
0.55
2.4
2.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
21
159
1.33
0.55
1.2
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
23
177
1.30
0.54
1.0
1.3
nmol/l
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
151
1379
1.11
0.54
1.6
1.6
%
1.4
1.4
0.56
134
1213
(3026389) Candida sp identified in Specimen by Organism specific culture
28
222
1.27
0.54
1.6
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
207
1921
1.09
0.54
2.7
2.5
e6/l
0.7
1.2
2.47
114
1026
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
128
1160
1.11
0.53
1.7
1.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
83
937
0.88
0.52
2.4
2.4
ml/min/173m2
67.6
69.9
0.21
36
357
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
9
63
1.43
0.52
1.0
1.0
—
10.4
—
0
9
(44790048)
9
134
0.67
0.52
1.3
1.3
—
—
—
0
0
(44790047)
9
134
0.67
0.52
1.3
1.3
—
—
—
0
0
(44806118)
9
134
0.67
0.52
1.3
1.3
—
—
—
0
0
(44790049)
9
134
0.67
0.52
1.3
1.3
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
24
188
1.28
0.51
3.1
2.3
%
13.3
13.1
0.54
24
188
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
135
1.34
0.51
1.2
1.1
—
—
—
0
0
(44813793)
15
109
1.38
0.51
1.1
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
50
426
1.18
0.50
1.7
1.9
iu/l
2.5
4.6
3.13
15
150
(3006315) Basophils [#/volume] in Blood
663
6423
1.06
0.50
5.2
5.6
e9/l
0.0
0.0
0.24
569
5594
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1254
12385
1.08
0.50
4.3
4.1
mmol/l
1.6
1.6
0.37
1149
11457
(3005082) Progesterone [Moles/volume] in Serum or Plasma
21
162
1.30
0.50
1.7
1.3
nmol/l
33.3
33.7
0.01
16
146
(3008037) Lactate [Moles/volume] in Venous blood
15
201
0.74
0.49
2.5
2.5
mmol/l
1.2
1.5
1.25
15
194
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
7
45
1.56
0.49
1.0
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
31
253
1.23
0.48
1.3
2.3
nmol/l
0.9
0.9
0.11
26
201
(3013650) Neutrophils [#/volume] in Blood by Automated count
771
7510
1.06
0.47
8.2
8.7
e9/l
4.2
4.0
2.68
689
6592
(3019060) Gas panel - Arterial blood
69
607
1.14
0.47
4.2
4.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
7
47
1.49
0.47
1.0
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
20
155
1.29
0.47
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
20
155
1.29
0.47
1.3
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
48
1.46
0.46
2.7
2.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
94
1.39
0.46
2.0
2.0
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
659
6399
1.05
0.45
5.1
5.6
e9/l
0.6
0.5
0.60
567
5575
(3021788) Differential panel - Synovial fluid
26
210
1.24
0.45
1.3
1.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
52
598
0.86
0.45
1.5
1.6
mg/l
3.8
3.9
0.03
36
406
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
67
592
1.14
0.44
1.6
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
33
275
1.20
0.43
1.3
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
20
157
1.28
0.43
1.3
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
28
230
1.22
0.42
1.3
1.2
u/ml
270.6
256.0
0.10
21
148
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
26
212
1.23
0.42
2.7
2.4
ug/min
70.0
74.8
0.03
11
130
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
32
1.56
0.42
1.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
96
871
1.11
0.42
1.6
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
56
491
1.15
0.42
2.0
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
16
206
0.77
0.41
2.1
2.2
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
8
58
1.38
0.41
2.0
1.6
nmol/l
1.0
1.4
—
8
49
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
141
1520
0.92
0.41
1.5
1.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
17
0.00
0.40
0.0
8.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1210
11959
1.06
0.40
14.0
13.1
%
39.2
39.1
0.26
855
8933
(3000492) Spirometry study
126
1162
1.09
0.40
1.4
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
16
123
1.30
0.40
1.1
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
21
168
1.25
0.40
1.6
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
33
278
1.19
0.40
1.0
1.1
u/ml
5.8
4.5
0.14
12
133
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
18
0.00
0.40
0.0
8.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
103
0.68
0.39
1.1
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
103
0.68
0.39
1.0
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1278
12656
1.07
0.39
4.7
4.5
mmol/l
2.8
2.8
0.02
1160
11683
(3047007) Chlamydophila sp Ab [Presence] in Serum
24
196
1.23
0.39
1.1
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
106
0.66
0.39
1.0
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
595
5782
1.05
0.39
2.3
2.3
nmol/l
78.3
77.9
0.14
538
5242
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
52
457
1.14
0.38
1.5
1.9
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
47
410
1.15
0.38
1.1
1.3
u/ml
4.0
11.0
—
5
77
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
9
66
1.37
0.38
1.2
1.3
—
1280.0
—
0
5
(3043410) Blood group antigens tested for on Red Blood Cells
5
36
1.39
0.38
1.6
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
26
215
1.21
0.38
1.0
1.0
u/ml
2.1
2.3
0.10
11
105
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
9
69
1.31
0.37
2.8
1.8
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
18
143
1.26
0.37
1.4
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1198
11849
1.06
0.36
3.8
3.7
mmol/l
1.2
1.2
0.30
1089
10883
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
235
2233
1.06
0.36
2.8
2.7
mmol/l
2.5
2.4
0.24
205
1952
(3012441) Differential panel - Pleural fluid
5
77
0.65
0.35
1.6
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
77
0.65
0.35
1.2
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
108
997
1.09
0.35
1.2
1.2
—
—
—
0
0
(4146454)
9
122
0.74
0.35
3.6
2.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
32
273
1.18
0.35
2.7
2.5
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
6
43
1.40
0.35
25.7
22.9
ug/l
95.2
96.5
—
6
34
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
6
44
1.37
0.34
1.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
50
443
1.13
0.34
1.2
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
11
82
1.34
0.34
1.3
1.1
—
—
—
0
0
(4024509)
18
145
1.24
0.33
1.3
1.6
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
6
45
1.33
0.33
1.3
2.0
%
28.3
28.2
—
6
40
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
14
109
1.29
0.33
1.3
1.1
mg/l
160.6
239.6
—
9
93
(3024891) Influenza virus A+B Ag [Presence] in Specimen
29
339
0.85
0.33
1.1
1.2
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
6
46
1.31
0.33
1.0
1.1
—
605.7
—
0
11
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
88
0.68
0.33
1.0
1.4
g/l
1.0
0.9
—
6
88
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
127
1186
1.08
0.32
2.1
2.2
u/l
36.2
36.4
0.01
106
995
(3006245) CD3-CD19+ cells/100 cells in Blood
6
47
1.28
0.32
1.3
2.0
%
17.2
8.9
—
6
42
(3047189) Immunofixation for 24 hour Urine
6
47
1.28
0.32
2.3
1.6
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
15
187
0.80
0.32
2.5
2.6
mmol/l
7.1
7.3
0.12
15
181
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
30
348
0.86
0.31
3.1
3.7
u/ml
17.1
32.6
2.02
30
343
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
230
0.82
0.31
1.1
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
230
0.82
0.31
1.1
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
43
380
1.14
0.31
1.3
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
24
202
1.19
0.31
1.3
1.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
52
1.35
0.31
1.0
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
113
1209
0.93
0.30
14.3
18.6
inr
1.1
1.2
0.70
19
201
(1002224) Polysomnography panel
53
477
1.12
0.29
1.1
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
108
0.74
0.29
1.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
16
130
1.23
0.28
1.8
2.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
54
488
1.11
0.28
9.2
8.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
41
460
0.89
0.28
1.4
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
70
642
1.09
0.28
2.6
2.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
112
1195
0.93
0.28
1.3
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
62
1.29
0.28
1.8
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
37
327
1.13
0.28
2.4
1.5
nmol/l
0.6
0.4
0.30
30
272
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
120
0.75
0.27
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
120
0.75
0.27
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
120
0.75
0.27
1.2
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
43
479
0.89
0.27
1.3
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
206
1.17
0.26
1.0
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
11
86
1.28
0.26
1.0
1.9
—
7.5
—
0
7
(3036782) Glucose [Moles/volume] in Pleural fluid
5
71
0.70
0.26
1.0
1.2
mmol/l
6.6
6.7
—
5
64
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
26
299
0.87
0.26
1.5
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
673
6606
1.03
0.26
5.2
5.6
e9/l
2.0
2.0
0.15
596
5880
(3015183) Erythrocyte sedimentation rate
9
74
1.22
0.25
1.2
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
52
570
0.91
0.25
1.6
1.6
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
14
114
1.23
0.25
1.2
1.2
mg/l
25.3
36.6
—
8
94
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
28
245
1.15
0.24
1.2
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
31
274
1.13
0.24
1.4
2.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
39
1.28
0.23
1.2
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
86
806
1.07
0.22
3.2
2.6
e9/l
69.7
73.4
0.46
64
588
(3000093) Morphology [Interpretation] in Blood Narrative
7
91
0.77
0.22
1.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
92
0.76
0.22
1.0
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
92
0.76
0.22
1.0
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
92
0.76
0.22
1.0
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
189
0.84
0.22
1.6
1.3
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
7
95
0.74
0.22
1.0
1.1
—
12.4
—
0
31
(3022313) Gas panel - Capillary blood
38
420
0.90
0.22
4.8
3.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
73
681
1.08
0.22
2.3
1.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
16
135
1.19
0.21
1.8
1.3
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
11
0.00
0.21
0.0
1.1
—
7.8
—
0
11
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(4212803)
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
48.5
—
0
11
(3014891) Appearance of Pleural fluid
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
3.1
—
17.7
—
0
10
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
10
0.00
0.21
0.0
1.0
—
8.3
—
0
10
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
10
0.00
0.21
0.0
1.0
—
35.9
—
0
10
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
10
0.00
0.21
0.0
1.0
—
21.2
—
0
10
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
8.8
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
12
0.00
0.21
0.0
4.8
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.2
—
2.7
—
0
7
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
43
1.16
0.21
1.0
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
43
1.16
0.21
1.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
30
268
1.12
0.20
1.0
1.1
u/ml
2.0
1.4
—
7
102
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
17
145
1.17
0.20
1.4
1.7
%
53.9
56.8
0.11
11
89
(3021879) Hepatitis B virus core Ab [Presence] in Serum
107
1127
0.95
0.20
1.4
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
14
0.00
0.20
0.0
5.5
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
48
1.25
0.20
1.3
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
48
1.25
0.20
1.7
1.5
nmol/l
113.7
133.4
—
6
48
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
92
973
0.94
0.20
2.3
2.4
au/ml
15.3
24.1
—
6
54
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
201
2082
0.96
0.20
4.1
3.2
ng/l
22.0
309.8
5.97
112
1394
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
114
1086
1.05
0.19
3.1
3.3
u/ml
33.8
52.1
1.14
107
1043
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
81
1.24
0.18
1.2
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
53
1.13
0.18
1.8
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
58
541
1.08
0.18
1.2
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
676
6666
1.03
0.18
5.4
5.9
e9/l
0.2
0.2
1.80
593
5894
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
112
1173
0.95
0.18
3.4
4.1
ug/l
88.3
10.9
0.46
88
930
(3037121) Protein [Mass/volume] in Urine
44
406
1.09
0.18
3.3
2.9
g/l
0.2
0.3
0.92
17
135
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
121
0.83
0.18
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
121
0.83
0.18
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
121
0.83
0.18
1.2
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
14
119
1.18
0.17
9.6
7.2
mg/l
14.1
12.1
0.95
14
111
(3004716) Salmonella sp identified in Stool by Organism specific culture
79
835
0.94
0.17
1.3
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
30
272
1.11
0.17
1.5
1.4
u/l
23.5
21.8
0.09
21
232
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
69
0.72
0.17
2.0
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
70
0.71
0.16
3.0
1.9
%
11.4
10.4
—
5
70
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
51
546
0.93
0.16
1.7
1.9
u/l
45.1
40.1
1.06
46
491
(4094501)
32
292
1.10
0.16
1.0
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
35
321
1.09
0.16
1.1
1.1
u/ml
7.2
1.1
—
8
118
(3004616) Nuclear Ab [Presence] in Serum
20
177
1.13
0.16
1.3
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
54
576
0.94
0.16
4.4
3.3
ph
7.4
7.4
—
7
73
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
72
1.11
0.16
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
72
1.11
0.16
1.0
1.1
—
—
—
0
0
(3020891) Body temperature
40
370
1.08
0.16
3.0
4.4
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
6
77
0.78
0.15
2.2
1.5
—
63.7
—
0
9
(40768806) Pleura Pathology biopsy report
6
78
0.77
0.15
1.5
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
32
293
1.09
0.15
1.2
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
318
3112
1.03
0.15
3.0
2.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
203
0.89
0.15
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
161
0.87
0.15
1.6
1.3
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
9
81
1.11
0.15
1.2
1.1
u/ml
—
6.7
—
0
10
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
88
0.79
0.14
1.1
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
24
264
0.91
0.14
3.7
3.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
114
1183
0.96
0.14
1.4
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
100
0.80
0.13
1.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
16
180
0.89
0.13
1.3
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
180
0.89
0.13
1.4
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
29
268
1.08
0.12
1.5
1.7
e6/l
5264.2
11057.3
1.18
18
194
(3021901) Oxygen saturation in Capillary blood
18
162
1.11
0.12
3.4
2.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
24
220
1.09
0.11
1.1
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
53
558
0.95
0.11
4.3
3.2
mmol/l
1.7
1.8
0.04
41
416
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
95
1.16
0.11
1.0
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1119
11244
0.98
0.11
5.9
5.1
mmol/mol
39.0
38.5
1.18
1038
10410
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
20
182
1.10
0.11
1.4
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
24
221
1.09
0.11
1.1
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
57
544
1.05
0.10
1.5
1.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
72
748
0.96
0.10
2.3
2.2
ug/l
7.0
5.8
0.14
66
660
(3038177) Helicobacter pylori Ab [Presence] in Serum
21
228
0.92
0.10
1.1
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
25
269
0.93
0.10
3.5
4.0
u/ml
0.4
0.4
0.29
16
159
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
45
1.11
0.09
1.4
2.1
ug/l
44.8
47.1
—
5
45
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
45
1.11
0.09
1.6
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
79
818
0.96
0.09
1.2
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
94
911
1.03
0.09
2.3
2.6
e9/l
4.2
4.1
0.10
75
740
(3011288) Drugs identified in Urine by Screen method
46
438
1.05
0.09
1.9
2.2
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
13
116
1.12
0.09
1.2
1.1
—
56.6
—
0
9
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
13
116
1.12
0.09
1.2
1.1
—
52.4
—
0
16
(3007930) Methemoglobin/Hemoglobin.total in Blood
35
370
0.94
0.09
6.1
4.8
%
1.0
0.9
0.60
35
349
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
54
1.11
0.09
2.3
1.4
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
55
1.09
0.09
4.7
2.1
ug/l
25.3
165.7
—
6
48
(3023430) Cat dander IgE Ab [Units/volume] in Serum
22
204
1.08
0.08
1.0
1.1
u/ml
1.8
5.2
—
6
74
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
61
587
1.04
0.08
1.2
1.3
miu/ml
236.9
238.2
0.01
30
293
(3034891) Synovial lining cells/100 cells in Synovial fluid
5
60
0.83
0.08
1.4
1.4
—
4.6
—
0
12
(4027681)
10
88
1.14
0.08
2.1
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
11
98
1.12
0.07
1.1
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
6
72
0.83
0.07
1.5
1.1
mmol/l
37.2
33.3
—
6
65
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
12
108
1.11
0.07
1.8
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
78
1.03
0.07
1.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
84
0.83
0.07
1.1
1.0
u/ml
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
84
0.83
0.07
1.7
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
35
367
0.95
0.07
3.1
3.5
u/ml
346.6
623.6
0.31
29
321
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
92
0.87
0.06
1.1
2.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
19
202
0.94
0.05
1.1
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
125
1271
0.98
0.05
1.2
1.2
iu/ml
77.1
154.9
2.39
38
496
(21494890) Protein electrophoresis panel - 24 hour Urine
10
110
0.91
0.05
1.7
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
112
1101
1.02
0.05
6.6
6.5
mmol/l
1.1
1.2
0.05
87
865
(4062490)
13
120
1.08
0.05
1.3
1.5
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
33
343
0.96
0.05
2.5
3.5
mmol/l
1.2
1.4
0.64
33
338
(36660697) Celiac disease serology panel - Serum
118
1199
0.98
0.04
1.2
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
25
262
0.95
0.04
1.4
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
44
454
0.97
0.04
2.0
1.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
28
268
1.05
0.04
1.4
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
130
0.92
0.04
1.8
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
130
1.08
0.04
1.4
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
75
766
0.98
0.04
7.3
7.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
15
160
0.94
0.04
2.7
1.7
%
63.8
59.8
0.32
15
160
(3009466) Valproate [Moles/volume] in Serum or Plasma
18
170
1.06
0.04
3.4
5.6
umol/l
379.3
382.9
0.04
13
142
(3020630) Protein [Mass/volume] in Serum or Plasma
87
856
1.02
0.03
4.0
2.8
g/l
66.2
67.0
0.54
73
780
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
38
370
1.03
0.03
5.7
4.7
%
2.0
1.6
1.06
38
347
(3027008) Opiates [Presence] in Urine
60
589
1.02
0.02
1.5
1.7
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
50
510
0.98
0.02
8.7
8.2
mmol/l
24.7
24.3
0.34
50
478
(4281824)
19
182
1.04
0.02
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
24
232
1.04
0.02
1.3
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
42
412
1.02
0.01
2.0
1.8
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
95
959
0.99
0.01
2.7
3.3
ng/l
87.4
78.2
0.29
76
831
(1001926) Buprenorphine [Presence] in Urine by Screen method
48
472
1.02
0.01
1.6
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
489
4902
1.00
0.01
1.8
1.9
pmol/l
101.1
98.6
0.43
236
2383
(3027944) Amphetamines [Presence] in Urine
57
578
0.99
0.01
1.5
1.7
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
23
223
1.03
0.01
1.0
1.0
u/ml
1.4
4.1
—
7
75
(3039000) Anion gap in Blood
21
204
1.03
0.00
8.5
6.8
mmol/l
10.4
11.1
0.80
21
186
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
28
286
0.98
0.00
7.2
3.8
mg/l
41.1
63.5
0.43
22
235
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
77
764
1.01
0.00
3.0
2.8
ng/l
150.3
142.9
0.10
65
699
(3035320) C reactive protein [Mass/volume] in Body fluid
10
96
1.04
0.00
2.3
2.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
96
1.04
0.00
1.0
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
104
0.96
0.00
1.6
2.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
22
216
1.02
0.00
6.6
4.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
39
394
0.99
0.00
2.1
1.6
iu/ml
47.9
0.2
—
9
74
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
111
0.99
0.00
1.4
1.2
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
12
119
1.01
0.00
1.3
1.5
g/l
0.4
0.4
—
6
84
(3027135) IgG subclass 1 [Mass/volume] in Serum
12
119
1.01
0.00
1.3
1.5
g/l
6.5
6.6
—
6
84
(3028192) IgG subclass 2 [Mass/volume] in Serum
12
119
1.01
0.00
1.3
1.5
g/l
2.6
2.9
—
6
83
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
16
161
0.99
0.00
1.2
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
36
361
1.00
0.00
1.1
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
59
591
1.00
0.00
1.5
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
313
3129
1.00
0.00
3.5
3.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
107
1.03
0.00
1.4
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
103
0.97
0.00
2.5
2.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
59
587
1.01
0.00
1.5
1.7
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
28
285
0.98
0.00
7.2
3.9
mg/l
36.0
38.2
0.10
22
236
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
31
315
0.98
0.00
1.1
1.2
—
0.6
—
0
5
(3024980) IgG subclass 4 [Mass/volume] in Serum
19
185
1.03
0.00
1.4
1.6
g/l
0.7
0.7
0.03
13
140
(3037756) Immunofixation for Serum or Plasma
22
225
0.98
0.00
2.3
1.6
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
21
205
1.02
0.00
8.5
6.8
mmol/l
104.4
105.5
0.63
21
187
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
23
225
1.02
0.00
1.5
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
135
0.96
0.00
1.2
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
70
1.00
0.00
1.0
1.1
miu/ml
1846.6
1524.2
—
7
70
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
9
0.00
0.00
0.0
3.3
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
5
0.00
0.00
0.0
2.0
—
374.0
—
0
5
(40758047) Lysozyme [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
4.7
—
0
6
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
61
0.98
0.00
1.0
1.2
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.5
—
193.0
—
0
8
(3051339) Copper [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
16.1
—
0
7
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
2.5
—
0
6
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
57
0.88
0.00
1.8
1.6
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
7
78
0.90
0.00
1.3
1.5
promille
1.4
1.2
—
7
58
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
54
0.93
0.00
1.0
1.4
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
8.4
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
5
0.00
0.00
0.0
1.2
—
65.4
—
0
5
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
61
0.98
0.00
1.0
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
83
0.96
0.00
1.1
1.6
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
61
0.98
0.00
1.0
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
64
0.94
0.00
2.2
3.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
5
59
0.85
0.00
1.0
1.1
u/l
263.0
421.9
—
5
53
(3017704) Immunofixation for Urine
5
53
0.94
0.00
2.8
1.8
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
7
73
0.96
0.00
2.1
3.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
100
1.00
0.00
2.6
3.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
130
1.00
0.00
1.0
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
57
0.88
0.00
1.8
1.6
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
85
0.94
0.00
2.4
2.3
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
61
0.98
0.00
1.0
1.2
—
—
—
0
0
(3022670) pH of Venous cord blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint O15_MATERN_CARE_CERVICAL_INCOMPETENCE and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have O15_MATERN_CARE_CERVICAL_INCOMPETENCE.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: O15_MATERN_CARE_CERVICAL_INCOMPETENCE – Maternal care for cervical incompetence

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data